US Companion Diagnostics Market Trends and Insights
US Companion Diagnostics Market Trends and Insights
Technological Advances and Promising New Drug Classes Create New Market Opportunities
RELEASE DATE
22-Apr-2014
22-Apr-2014
REGION
North America
North America
Research Code: 9837-00-7C-00-00
SKU: LS00212-NA-MR_17472
$1,500.00
Special Price $1,125.00 save 25 %
In stock
SKU
LS00212-NA-MR_17472
Description
A complete companion diagnostic market analysis must include both developers of targeted drugs and developers of companion diagnostic tests. This research deliverable discusses important trends in the U.S. companion diagnostics market including emerging opportunities with novel drug classes and new clinical markers like circulating tumor cells. Emerging therapeutic areas beyond oncology for companion diagnostics are also discussed along with key competitors, rx-cdx partnerships, regulatory overview, and therapeutic pipelines with companion biomarkers.
Table of Contents
Overview
Related Research
Popular Topics
A complete companion diagnostic market analysis must include both developers of targeted drugs and developers of companion diagnostic tests. This research deliverable discusses important trends in the U.S. companion diagnostics market including emerging opportunities with novel drug classes and new clinical markers like circulating tumor cells. Emerging therapeutic areas beyond oncology for companion diagnostics are also discussed along with key competitors, rx-cdx partnerships, regulatory overview, and therapeutic pipelines with companion biomarkers.
No Index | No |
---|---|
Podcast | No |
Author | Divyaa Ravishankar |
WIP Number | 9837-00-7C-00-00 |
Is Prebook | No |